Biologics Manufacturing Insights | Resilience

Resilience Acquires SwiftScale Biologics, A Leader In Cell-Free Protein Synthesis Technology

Written by Resilience | Dec 2, 2021, 5:00:00 AM

SAN DIEGO--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a technology focused manufacturing company dedicated to broadening access to complex medicines, today announced the acquisition of SwiftScale Biologics, a San Leandro, California-based company developing cell-free protein synthesis (CFPS) technology.

Click here to read the full press release from Business Wire.